21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [Enilloring]
RxNorm concept 2644707, branded drug (sbd). Prescribable name: EnilloRing 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System.
- RxCUI
- 2644707
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2644707 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
EnilloRing 0.12/0.015 MG per 24HR 21 Day Vaginal System
Related concepts
- etonogestrel 0.005 MG/HR (SCDC, consists of)
- ethinyl estradiol 0.000625 MG/HR (SCDC, consists of)
- ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR [Enilloring] (SBDC, consists of)
- Vaginal System (DF, has dose form)
- Enilloring (BN, has ingredient)
- 21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2644707 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2644707 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2644707. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.